Yvonne Rivera Romero is categorized under Clinical Laboratory Instruments, Except Medical and Dental in , and active since 1980.
Yvonne Rivera Romero was established in 1980, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Clinical Laboratory Instruments, Except Medical and Dental business, which does work in the B2B market, and is classified as a Clinical Laboratory Instruments, Except Medical and Dental, under code number 333249 by the NAICS.
If you are seeking more information, feel free to contact Yvonne Rivera Romero at the company’s single location by writing to 21 Luis Munoz Rivera Avenue, , 00692 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Yvonne Rivera Romero |
Contact Person: | Yvonne Rivera Romero |
Address: | 21 Luis Munoz Rivera Avenue, , 00692 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1980 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Clinical Laboratory Instruments, Except Medical and Dental |
SIC Code: | 3821 |
NAICS Code: | 333249 |
Share This Business: |
Yvonne Rivera Romero was started in 1980 to provide professional Clinical Laboratory Instruments, Except Medical and Dental under the SIC code 3821 and NAICS code 333249. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Yvonne Rivera Romero for inquiries that concern Yvonne Rivera Romero by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Yvonne Rivera Romero can be found at the coordinates as well as the street address 21 Luis Munoz Rivera Avenue in , 00692.
For its online presence, you may visit Yvonne Rivera Romero’s website at and engage with its social media outlets through on Twitter and on Facebook.